More Images
LOS ANGELES—Second Sight Medical Products (NASDAQ: EYES) announced March 12 that Will McGuire, president and chief executive officer, is exiting the company, effective March 27, 2020, to pursue “another professional opportunity located closer to his family.” McGuire remains as a director on Second Sight’s board. Effective March 27, 2020, Gregg Williams, the company’s chairman of the board, will assume the role of acting CEO. Reporting to him will be John T. Blake, chief financial officer and Pat Ryan, chief operating officer. The board is initiating a search process in order to identify the future CEO.

Second Sight develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals.